Basic Information
Solexa mainly engages in the development and commercialization of genetic analysis technologies in the United States and the United Kingdom. The company is developing and manufacturing the Solexa Genome Analysis System, which is based on its proprietary reversible terminator sequencing synthesis, chemistry, and clonal single-molecule array technology for DNA sequencing. Its platform is designed to support a range of analyses, including whole-genome resequencing, gene expression analysis, and small RNA analysis.
Solexa
California,United States of America
101~500 people
January 01, 1998
--
--

